Loading...

Poolbeg Pharma PLC

POLBF•PNK
Healthcare
Biotechnology
$0.06
$0.00(0.00%)
U.S. Market opens in 7h 35m

Poolbeg Pharma PLC (POLBF) Stock Overview

Explore Poolbeg Pharma PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap42.2M
P/E Ratio-3.94
EPS (TTM)$-0.01
ROE-0.54%
Fundamental Analysis

AI Price Forecasts

1 Month$0.07
3 Months$0.00
1 Year Target$0.00

POLBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Poolbeg Pharma PLC (POLBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.94 and a market capitalization of 42.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
40.71%
6-Month Change
40.71%
Year-to-Date (YTD) Change
40.71%
1-Year Change
-49.32%
3-Year Change
-48.00%
5-Year Change
-35.35%
All-Time (Max) Change
-35.35%

Contact Information

https://www.poolbegpharma.com
44 20 7183 1499
Queen Mary BioEnterprises Innovation Ctr, London, NaN, E1 2AX

Company Facts

15 Employees
IPO DateApr 1, 2022
CountryGB
Actively Trading

Frequently Asked Questions